This presentation discusses psychosocial challenges that can arise before, during and after a bone marrow/stem cell transplant or CAR T-cell therapy, strategies to manage them, resources that can help, and when to consult a mental health professional.

Cancer-related fatigue can be managed, and endurance can be rebuilt. Learn about strategies to conserve energy; adaptive equipment that can help with energy conservation; and improving stamina and strength through exercises that patients can perform at home. Also learn to identify when it is appropriate to seek help from a physical or occupational therapist.

Many patients experience significant fatigue for months or years after a stem cell transplant or CAR T-cell therapy. Learn a variety of strategies you can try to manage chronic fatigue and lessen its impact on your daily activities.

El trasplante y la terapia de células CAR T han curado y prolongado las vidas de muchísimas personas con cánceres hematológicos. Sin embargo, los sobrevivientes pueden presentar complicaciones cardiovasculares en el corto y largo plazo. Conozca cuáles son esas complicaciones y cómo prevenirlas.

People who have undergone a bone marrow or stem cell transplant have an increased risk of osteopenia (loss of bone density), osteoporosis and bone fractures. Periodic bone density tests are needed to monitor bone health so that therapies can started early to prevent or reverse bone loss.

Pueden desarrollarse nuevos cánceres después de un trasplante de células madre. Esta presentación describe qué tipos de cánceres pueden desarrollarse, los factores de riesgo y las medidas que puede tomar para prevenir y detectar nuevos cánceres después del trasplante.

Graft versus Host Disease (GVHD) is a common complication after allogeneic stem cell transplant. Learn the difference between acute and chronic GVHD and how each develops. Both standard therapies and exciting new prevention and treatment interventions are discussed.

Multiple studies have shown that most patients who receive chimeric antigen receptor (CAR) T-cell therapy report a good quality of life long-term. Learn how CAR T-cell therapy is performed and its short-term and long-term effects on patients and caregivers. Discover key differences between CAR T-cell, stem cell transplant and other and chemotherapy treatments.

Advanced age has traditionally been seen as prohibitive for treatments like stem cell transplants and CAR T therapy. This presentation reviews evidence that overall fitness is a crucial factor in reducing non-relapse mortality and that otherwise healthy elderly patients can have successful outcomes after transplant and CAR T-cell therapy.

La terapia de células CAR T es un tratamiento nuevo para pacientes que tienen ciertos tipos de linfoma no Hodgkin. Conozca lo que implica someterse a una terapia de células CAR T, quién es un buen candidato y los posibles resultados.